Skip to main content
. 2017 Oct 5;7(10):e017052. doi: 10.1136/bmjopen-2017-017052

Table 4.

Number and percentage of patients in trial by whether a TYAC form was received by age group in 2009–2010

Age Proportion of patients with a TYAC form who were in trial Proportion of patients without a TYAC form who were in trial p Value
Proportion Percentage 95% CI Proportion Percentage 95% CI
15–19 45/57 78.9 66.7 to 87.5 19/30 63.3 45.5 to 78.1 0.117
20–24 16/26 61.5 42.5 to 77.6 8/22 36.4 19.7 to 57.0 0.082
15–24 61/83 73.5 63.1 to 81.8 27/52 51.9 38.7 to 64.9 0.011